Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Earnings Preview: Pacific Biosciences of California (PACB) Q2 Earnings Expected to Decline
04:05pm, Tuesday, 27'th Jul 2021
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PacBio (PACB) Enhances Sequencing Platform Via Latest Buyout
08:27am, Friday, 23'rd Jul 2021
PacBio's (PACB) latest acquisition is expected to deliver the most advanced blend of sequencing solutions to transform the genomics landscape.
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
10:14am, Tuesday, 20'th Jul 2021
Pacific Biosciences of California Inc (NASDAQ: PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. Under the terms of the agreement, PacBio
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
07:02am, Tuesday, 20'th Jul 2021
Collaboration to develop production-scale HiFi Sequencing platform expected to Include technology from Omniome, Inc.
Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call
04:05pm, Monday, 19'th Jul 2021
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial result
Where Will ARK Genomic Revolution ETF Be in 5 Years?
06:12am, Saturday, 10'th Jul 2021
Cathie Wood's genomics ETF is making big bets on the "Genomic Age."
Pacific Biosciences (PACB)-RCIGM Tie Up for Sequencing Research
12:09pm, Tuesday, 29'th Jun 2021
Pacific Biosciences' (PACB) latest research tie-up is likely to use HiFi Sequencing data on some of the most difficult cases of rare pediatric disease and provide insights into the treatment journey.
Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing
04:05pm, Wednesday, 23'rd Jun 2021
HiFi Sequencing will be used on a cohort of rare disease cases with the aim to identify numerous variants, both small and structural, that are not readily detectable by short-read sequencing HiFi Sequ
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:05pm, Friday, 11'th Jun 2021
MENLO PARK, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequen
Industry Veteran Will Lead PacBio's Commercial Footprint Across the Region Industry Veteran Will Lead PacBio's Commercial Footprint Across the Region
This Biotech Just Made History. Will Its Stock Follow?
12:55pm, Friday, 04'th Jun 2021
Twenty years after the human genome was sequenced, a new wave of discovery has begun.
The Pullback In Pacific Biosciences Makes For A Much More Interesting Opportunity
04:30pm, Wednesday, 26'th May 2021
PacBio saw strong system placements in the first quarter, including multiple multi-system orders, multiple new customers, and orders for COVID-19 surveillance.
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:05pm, Friday, 21'st May 2021
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequenc
3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming
06:16am, Thursday, 13'th May 2021
Falling costs are ushering in a new era of screening for a dreaded disease.
Pacific Biosciences (PACB) Down 10.8% Despite Narrower Q1 Loss
01:31pm, Monday, 03'rd May 2021
Pacific Biosciences' (PACB) revenues grow in both its segments during the first quarter.
